Advertisement UCB research links RLS to CV disease - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

UCB research links RLS to CV disease

Patients were significantly more likely to develop cardiovascular (CV) conditions, including hypertension, cardiac dysrhythmias and chronic ischemic heart diseases after an initial diagnosis of restless legs syndrome (RLS), as compared to controls without RLS, according to a two-year retrospective cohort study by UCB.

The study matched the US medical records of 3,485 RLS patients to those of 3,485 patients without RLS.

The most frequent CV diagnoses observed were hypertension (48%), cardiac dysrhythmias (9.3%), chronic ischemic heart diseases (8.5%), occlusion and stenosis of cerebral arteries (2.81%), cardiomegaly (2.50%), and hypertensive heart disease (2.43%).

UCB Global Epidemiology head, the University of Liege Epidemiology adjunct professor and the author of the study Florent Richy said the findings confirm the need for early diagnosis of RLS so that patients can be monitored for subsequent development of serious cardiovascular events.